Letter

Poor prescribing is continual

BMJ 2006; 333 doi: 10.1136/bmj.333.7571.756-b (Published 5 October 2006)
Cite this as: BMJ 2006;333:756.3

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Jeffrey K Aronson, president-elect,
  2. David B Barnett, past treasurer, clinical section,
  3. Robin E Ferner, chairman, clinical section committee,
  4. Albert Ferro, vice president (clinical),
  5. Graeme Henderson, president,
  6. Simon R Maxwell, past vice president (clinical),
  7. Michael D Rawlins, honorary fellow,
  8. David J Webb, chairman, committee of heads and professors of clinical pharmacology
  1. British Pharmacological Society, London EC1V 2SC

    EDITOR—An editorial should bring an important topic to readers' attention and engage their interest, provoke a reaction, and trigger debate. We are delighted that the recent editorial on poor prescribing in the United Kingdom seems to have done all of these things.1

    We did not give a thorough account of all the evidence, but we are surprised that Rubin thinks that we provided no evidence at all.2 We cited …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    Read related article

    See previous polls

    BMJ most popular